Showing results (51-60 of 483) with videos related to
Sort By:
Pageof 49
Prostaglandins|June 1, 1990
A double blind placebo controlled trial of intravenous prostacyclin (PGI2) in 108 patients with ischaemic peripheral vascular diseaseI Virgolini, P Fitscha, O I Linet, et al.Prostaglandins|January 1, 1996
Prostaglandin E1 decreases circulating endothelial cellsH Sinzinger, P Fitscha, H Kritz, et al.Blood Pressure. Supplement|January 1, 1994
Influence of calcium antagonists on platelet function and vascular prostacyclin productionC Pirich, P Schmid, P Fitscha, et al.Thrombosis Research|May 1, 1994
Isradipine decreases arterial thrombogenicity in rabbits. A morphometric and radioisotopic studyP Fitscha, A Keiler, J O'Grady, et al.Prostaglandins, Leukotrienes, and Medicine|August 1, 1987
Prostacyclin synthesis stimulating plasma factor in patients with peripheral vascular diseaseE Strobl-Jäger, P Fitscha, J Kaliman, et al.Journal of Cardiovascular Pharmacology|May 1, 1985
Transient drug-induced myocardial dysfunction is not ameliorated by PGI2 in dogsP Fitscha, G Krumpl, R Seitelberger, et al.Prostaglandins, Leukotrienes, and Essential Fatty Acids|December 1, 1989
Beneficial effect of long-term PGE1-treatment in left ventricular heart failureI Virgolini, J Kaliman, P Fitscha, et al.Prostaglandins|June 1, 1987
Prostaglandin I2 reduces activation of human arterial smooth muscle cells in-vivoH Sinzinger, T Zidek, P Fitscha, et al.Prostaglandins, Leukotrienes, and Medicine|March 1, 1985
The prostacyclin synthesis stimulating plasma factor is unchanged during acute angina pectorisH Sinzinger, J Kaliman, P Fitscha, et al.Blood Pressure. Supplement|January 1, 1994
Isradipine increases platelet--low-density lipoprotein binding: evidence from ex-vivo studies in humansP Schmid, C Pirich, P Fitscha, et al.Pageof 49